Soare A, Weiss EP, Pozzilli P
Methodologically akin to a retrospective cohort analysis, our study differs in that it emulates a target trial by prespecifying the protocol, aligning index date, and using propensity score matching to emulate randomization, thereby reducing immortal-time bias, improving transparency, and aligning real-world evidence generation with clinical trial standards
Phase 3 trials (SURMOUNT trials) showed dose-dependent weight loss: 1422% reduction over 68 weeks depending on dose tier
In the kidney, we observed widespread disruption in energy metabolism and multiple molecules involved in glycolysis, gluconeogenesis, and the TCA cycle were depleted, indicating a more global disruption in energy metabolism than has been previously appreciated
Bookmark the correct portal, keep your credentials private, and never share one-time codes